Galectin Therapeutics shares owned by Argyle Capital Partners
Quarter-by-quarter ownership of Galectin Therapeutics (GALT) shares owned by Argyle Capital Partners
from 13F filings
Historical chart of Argyle Capital Partners investment in Galectin Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Galectin Therapeutics held by Argyle Capital Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Galectin Therapeutics by Argyle Capital Partners
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $57k | 13k | 4.24 |
| 2025-06-30 | $28k | 13k | 2.11 |
| 2025-03-31 | $16k | 13k | 1.22 |
| 2024-12-31 | $17k | 13k | 1.29 |